Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | MAOA | P21397 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | PLA2G2A | P14555 | 4/20 | 0.41 |
| ▸ | PLA2G4A | P47712 | 4/20 | 0.41 |
| ▸ | AHR | P35869 | 3/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17944857 | 0.96 | MAPT (0.50) | HPGDKDM4EALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL17944992 | 0.95 | PLA2G2A (0.45) | HPGDKDM4EALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL26492196 | 0.95 | MAPT (0.41) | HPGDKDM4EALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL24519042 | 0.95 | AHR (0.44) | HPGDKDM4EALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL24518935 | 0.93 | AHR (0.47) | HPGDKDM4EALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL17944089 | 0.93 | PLA2G2A (0.48) | HPGDKDM4EALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL24519043 | 0.91 | AHR (0.47) | HPGDKDM4EALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL17944470 | 0.90 | CASP3 (0.41) | HPGDKDM4EALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL17945596 | 0.90 | PLA2G2A (0.50) | HPGDKDM4EALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL24518934 | 0.90 | ALOX5 (0.39) | HPGDKDM4EALDH1A1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11367838-B2 | Anthracene derivative and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2022-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11367838-B2 | Anthracene derivative and organic light-emitting device comprising same | CCNL2, CRY1, CYP2S1 | HPGD 2297/4885KDM4E 3061/4885ALDH1A1 434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.